Mudjianto Chandra, MD
Colon & Rectal Surgery · Tarzana, CANPI 1225152515
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,195 of the $11,030 with a category attached, or 65.2%. Intuitive Surgical accounts for 90.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $9,260 and has fallen 95.6% since, to $405 in 2023.
Across 36 payments — averaging $306.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Applied Medical Resources Corporation$745
- Innocoll Pharmaceuticals Limited$130
- KARL Storz Endoscopy-america$112
- Davol Inc.$14
What the payments were for
- Travel & lodging$2,21520%
- Food & beverage$1,35212%
- Education$7,19565%
- Gifts$2692%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 25 | $10,030 |
| Applied Medical Resources Corporation | 2 | $745 |
| Innocoll Pharmaceuticals Limited | 6 | $130 |
| KARL Storz Endoscopy-america | 2 | $112 |
| Davol Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,335
- VOYANT$731
- STAPLING$731
How this compares
$11,030 in reported general payments places this provider in the 70th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 77 | $1,035 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $520 |
| CefuroximeCefuroxime Axetil | 74 | $456 |
| Ciprofloxacin Hcl | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Tarzana
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Joseph CarmichaelOrange$99K
- Phillip FleshnerWest Hollywood$95K
- Zuri MurrellBeverly Hills$86K
- Lorenc MalellariBakersfield$78K
- Ankit SarinSacramento$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.